Latest Safety News

MC Mining reports steady progress at its Makhado steelmaking coal project in South Africa alongside a significant increase in Kinetic Development Group's shareholding to 44%. The company maintains its production targets for 2026 amid strong safety and environmental records.

Spacetalk Ltd has signed a non-binding MOU with Vodafone Australia to distribute its Family Safety software platform, marking a strategic shift towards a software-led business model and aiming for significant recurring revenue growth.

Nanosonics Limited reported a 9% revenue increase in the first half of FY26, driven by a growing installed base and recurring sales, while advancing the commercial rollout of its new CORIS endoscope reprocessing system.

AMA Group Limited reported a robust 21.9% rise in pre-AASB 16 Normalised EBITDA to $30.5 million for the first half of FY26, driven by revenue growth and operational improvements across key segments. The company is targeting a 10% EBITDA margin in its core vehicle collision repair business within the next 3-4 years.

Etherstack plc reported a robust FY2025 financial rebound with revenue soaring 70% to US$10.1 million, driven by major US project deliveries and a 62% rise in recurring support revenues. The company also turned EBITDA positive and secured key long-term contracts, setting the stage for strong growth in 2026.

Lark Distilling Co. has reported a solid 10% increase in net sales revenue for the first half of FY26, driven by strong whisky sales and international expansion. The company is gearing up for a major global portfolio launch in the second half, backed by a refreshed brand and enhanced production capacity.

Emerald Resources NL reported a 23% rise in half-year profit to $73.1 million, underpinned by solid gold production at its Okvau Gold Mine and significant progress across its Cambodian and Australian projects.

Coronado Global Resources reported a $432.1 million net loss for FY2025, impacted by a 22% revenue decline due to softer metallurgical coal markets and logistical challenges. Despite operational gains and cost cuts, the company strengthened liquidity through refinancing and support from Stanwell.

PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.

Perennial Investment Management has launched the Ziller Global Fund Active ETF (ASX: ZILR), targeting high-growth global companies led by exceptional founders. The fund aims to deliver absolute returns above the MSCI All Country World Index over a typical five-year horizon.

Neurotech International has reported positive long-term safety results for its lead drug candidate NTI164, bolstering its path towards regulatory approval and chronic use in paediatric neurological disorders.

Clarity Pharmaceuticals reports another metastatic prostate cancer patient achieving undetectable disease markers in its Phase II SECuRE trial, reinforcing promising efficacy and safety of its Cu-SAR-bisPSMA radiopharmaceutical.